Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

Recruiting

• Conditions: Atopic Dermatitis; Mycosis Fungoides; Sezary Syndrome; Cutaneous T-cell Lymphoma; Eczema

• Registration Number: NCT00177268
• Lead Sponsor: University of Pittsburgh

Brief Summary

This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.

Detailed Description

The purpose of this study is to provide a central mechanism for monitoring access to peripheral blood, urine, and skin specimens obtained from CTCL, eczema, and atopic dermatitis patients to monitor:

* immunologic assays/flow cytometry

* tumor progression/regression

* genomic studies

* proteomic studies

* others germane to the advancement of CTCL treatment

Study Timeline

• Study Start: 2004-10
• Study First Submitted: 2005-09-12
• Study First Submitted QC: 2005-09-12
• Study First Posted: 2005-09-15
• Status Verified: 2025-01
• Last Update Submitted: 2025-01-06
• Last Update Posted: 2025-01-08
• Primary Completion: 2030-01
• Study Completion: 2032-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• 18 or older
• able and willing to provide informed consent
• diagnosed with CTCL
• diagnosed with either atopic dermatitis or eczema

Exclusion Criteria

• Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proteomics of Cutaneous T-cell lymphoma	Ongoing	Proteomic variables will be measured in blood and tissue of consented CTCL patients.

Trial Locations

Locations (1)

University of Pittsburgh Medical Center; 🇺🇸 Pittsburgh, Pennsylvania, United States